Allogeneic cultured keratinocytes and fibroblasts - Organogenesis

Drug Profile

Allogeneic cultured keratinocytes and fibroblasts - Organogenesis

Alternative Names: Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen; Gintuit

Latest Information Update: 06 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organogenesis
  • Class Cell therapies
  • Mechanism of Action Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Gingival disorders
  • Discontinued Alveolar bone loss

Most Recent Events

  • 10 Dec 2013 Organogenesis completes enrolment in its phase I/II trial for Gingival disorders & Alveolar bone loss following tooth extraction in the USA (NCT01929954)
  • 31 Jul 2013 Phase-I/II clinical trials in Alveolar bone loss in USA (Topical)
  • 08 Apr 2013 Launched for Gingival disorders to a controlled market in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top